Advancing science for longer, better lives.
MELLOW connects researchers, clinical sites, industry partners, scientific publishers, and longevity professionals across six continents, turning fragmented studies into one harmonized body of global evidence.
Find the MELLOW built for you
Seven doorways into one platform. Tell us who you are, and we'll take you to what matters: benefits, requirements, and the fastest route to getting started.
Wellness & Biotech Company
Run trials or partner on biomarker and formulation research.
Clinical Investigator
Lead or join harmonized multi-country trials.
Academic Institution
Contribute sites, cohorts, or shared research infrastructure.
Individual
Explore MELLOW-Age and track your own biological age.
Healthcare Provider
Offer MELLOW-Age care plans to your own patients.
Hospital or Wellness Group
Bring your team onto the MELLOW-Age clinical dashboard.
Journal or Conference Partner
Partner with JLIVE publishing or the Annual Meeting.
Not sure yet?
Take a 60-second tour of the full MELLOW ecosystem.
A global network of research & clinical excellence
Explore MELLOW member institutions and clinical sites across six continents on the interactive map. Select any location to see its specialties, investigators, and active studies, or switch to the globe view.
An integrated global ecosystem
Each division stands on its own and grows independently, yet they share one network, one brand, and one flow of evidence from trial to publication to practice.
MELLOW Consortium
Harmonized multinational trials, industry partnerships, institutions, and investigators.
Enter division →MELLOW Consortium
Harmonized multinational trials, industry partnerships, institutions, and investigators.
Enter division →MELLOW-Age
Biological-age intelligence and personalized, localized wellness planning.
Enter division →JLIVE
Rigorous, fair peer review in longevity and integrated vitality evidence.
Enter division →Conferences
Global scientific events, member discounts, and the MELLOW Annual Meeting.
Enter division →News & Updates
Consortium news, blogs, discoveries, and global updates from the network.
Enter division →Built to fix what fragments longevity research
Country-by-country studies are slow, costly, and hard to compare. MELLOW replaces that with shared infrastructure and one harmonized program.
Global Trials
One protocol runs across six continents with diverse, representative populations.
Shared Placebo Arms
Pooled control infrastructure cuts cost and speeds parallel evidence generation.
KOL Network
Pre-vetted investigators and thought leaders ready to design, run, and speak.
Standardized Biomarkers
Harmonized panels and endpoints make results comparable across every site.
Publication Pathway
A built-in route from trial data to peer-reviewed publication in JLIVE.
International Visibility
Conferences, media, and a global platform amplify every finding worldwide.
Advancing the science of healthy aging
Together with academic collaborators, the MELLOW Consortium is building a network of longevity research programs. The network is still growing; these are the areas we're focusing on:
Active clinical trials
Live studies across the network. Explore by region, check eligibility, or sponsor a shared-arm trial of your own.
Metformin and Healthspan in Pre-Diabetic Adults
Evaluating whether early metformin intervention slows metabolic ageing markers in pre-diabetic adults aged 50-70.
Multinational Biological Age Clock Validation Study
The Consortium's flagship trial: validating a shared biological-age clock across seven countries and diverse ancestries: one protocol, one budget, one dataset.
Know your biological age. Improve how you age.
Share your lab results with a connected MELLOW provider, get your biological age assessed and recorded, and follow a personalized care plan you build together.
Chronological age 57 · ageing 6 years younger
Built for the people delivering care
One connected platform for the clinicians practising wellness medicine and the organisations they work in.
A clinical dashboard built for modern wellness medicine
- Live patient roster with risk stratification and biological age across your entire panel.
- Care plan builder: push diet, exercise, meditation, and medication plans to patients instantly.
- Personalised recommendations that appear straight in each patient's dashboard.
- Secure messaging with your patients, plus a shareable video meeting link for teleconsultations.
- Clinical visits, diagnoses, and lab report history all in one place.
Manage your entire clinical team from one portal
- Multi-location management: add locations, assign providers to branches, and manage your full team.
- Schedule management: set provider availability week by week.
- Network analytics: active providers, patients, visit volume, and specialty mix across your locations.
- Role-based access control: providers see only their own patients, hospital admins see their own network, and superadmins manage all hospitals.
Your health data is yours
Encrypted and access-controlled
Your data is encrypted in transit and at rest. You see your own records, and providers see only the patients connected to them.
How your biological age is determined
Your connected provider reviews your lab results and records your biological age. It isn't generated automatically.
Not a diagnostic tool
MELLOW is not a diagnostic tool and does not provide medical diagnoses. All clinical decisions remain with the treating provider.
Not emergency care
MELLOW is a wellness and preventive health platform. It is not a substitute for emergency medical care. If you have an urgent health concern, contact your doctor or emergency services immediately.
Founded by translational science leaders
Amara Whitfield
Translational scientist with two decades in multinational trial design, focused on making longevity evidence reproducible across populations.
Jonas Lindqvist
Previously built research-network infrastructure across three continents; now focused on aligning the Consortium's member institutions under one shared protocol standard.
One trial. Six continents. One budget.
Generate credible, multi-country clinical evidence at 30–50% lower cost and up to 40% faster, without building your own global research infrastructure.